BenchSci Expands Advisory Board with New Pharma R&D Leaders
BenchSci has welcomed three new members to its advisory board from the pharmacology sector. Steve Hitchcock of Takeda…
EF Hutton Initiates Coverage of Cel-Sci (CVM) with $17 Price Target Ahead of Rumored News
Tim Moore, CFA an Analyst at EF Hutton has recently published a report citing the opportunities for growth…
Legend Biotech Appoints Dr. Guowei Fang As Head of Global Research and Early Development
Global biotechnology company Legend Biotech Corporation (NASDAQ: LEGN) announced today that Guowei Fang, Ph.D. will take over as…
2seventy bio Secure $170 Million Extending Cash Runway Into 2025
2seventy bio (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today announced that it has agreed to sell…
Inhibikase Therapeutics To Present Phase 1/1b Trial Results at AD/PD Alzheimer’s & Parkinson’s Diseases Conference
Clinical-stage pharmaceutical company Inhibikase Therapeutics, Inc. (Nasdaq: IKT) recently announced that President and CEO Dr. Milton Werner, Ph.D. will be…
Celyad Oncology Pauses CYAD-101-002 (Keynote-B79) Phase 1 Trial After 2 Deaths Reported
Clinical-stage biotechnology company Celyad Oncology (NASDAQ: CYAD) recently announced that the company has voluntarily paused the CYAD-101-002 (KEYNOTE-B79)…
Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
With the appointments of these experts, the firm has added to its industry knowledge, including Chief Scientific Officer…
Nasdaq Biotechnology Index Adds Quantum-Si (Nasdaq: QSI) Life Sciences Company
Quantum-Si (Nasdaq: QSI), a life science instrumentation firm commercializing a distinctive protein sequencing technology, has been added to…
Sigilon Therapeutics Provides Update on Strategic Reprioritization
San Francisco, California-based biotechnology firm Sigilon Therapeutics, Inc. (NASDAQ: SGTX) has announced a strategic re-prioritization to enable the…
MacroGenics Announces Failure in SOPHIA Study of MARGENZA for Metastatic Breast Cancer Patients
Biopharma MacroGenics, Inc. (NASDAQ: MGNX) announced that the final overall survival (OS) analysis did not demonstrate a statistically…
Infinity Pharmaceuticals Add 2 New Members to Board of Directors
Clinical-stage biotech Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced the change of 2 new Board of Directors roles including…
Capricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD)
Capricor Therapeutics Announces HOPE-2 Trial Data Presentation On September 2nd, Capricor Therapeutics (NASDAQ: CAPR) announced an upcoming company…
Oracle Health Raises $2.7M from Investors, Turns Down Y Combinator Funding
Innovative medtech company Oracle Health has raised over $2.7 Million from investors through the Republic platform. The company…
Denali Therapeutics Announces Scientific Journal Publication of Preclinical Proof of Concept for Protein Transport Vehicle (PTV)
Pre-clinical research published in Cell highlights new approach to treat FTD-GRN with enhanced brain uptake of progranulin through…
Istari Oncology Begins Phase 1 / Phase 2 Sub-Study To Evaluate PVSRIPO in Head and Neck Cancer Patients
Istari Oncology, Inc., a clinical-stage biotechnology firm focused on unique immunotherapy systems for the treatment of strong lumps,…
Altasciences Appoints Bruce Frank as Vice President, CDMO Operations
Altasciences introduced the appointment of Dr. Bruce Frank, PhD, as Vice President, CDMO Operations. Bruce has thirty years…
Advanced Chemotherapy Technologies Receives $4 Million NIH Grant to Pursue Pancreatic Cancer Treatment
Clinical-stage drug delivery company Advanced Chemotherapy Technologies (ACT) announced that the company has been awarded a Phase IIb…